MNPR

NASDAQ · Equity

Monopar Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
65.040000
Fair value
27.758915
Expectation
Undecided 49.08%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
65.04
12-Week Change
7.75%
Trend Signal
Inactive
Expectation
Undecided 49.08%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-9.94
Market Dynamics
0.63

Over the latest 12 completed weeks ending 2026-05-29, MNPR rose 7.75%, moving from 60.36 to 65.04. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -9.94 and has softened across the 12-week window. Market Dynamics is 0.63 on the latest week. Expectation is undecided at 49.08%.